Literature DB >> 32007430

The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial.

Willy Baccaglini1, Cristiano Linck Pazeto2, Eduardo Augusto Corrêa Barros2, Frederico Timóteo2, Leonardo Monteiro2, Raiff Yusser Saad Rached2, Arthur Navas2, Sidney Glina2.   

Abstract

BACKGROUND: Erectile dysfunction (ED) after radical prostatectomy (RP) still represents a major issue. Considering the benefits recently described regarding the application of low-intensity extracorporeal shockwave therapy (LiESWT) in vasculogenic ED, questions arise about its role in the scenario of penile rehabilitation. AIM: To compare the early introduction of phosphodiesterase-5 inhibitor (PDE5i) with a combination therapy enrolling both early PDE5i use and LiESWT in patients submitted to RP.
METHODS: This study is a randomized clinical trial, open-label, with 2 parallel arms and an allocation ratio of 1:1. The study was registered in ReBEC (ensaiosclinicos.gov.br) Trial: RBR-85HGCG. Both arms started tadalafil at a dose of 5 mg/day right after the removal of the transurethral catheter, and the experimental group received 2,400 shocks/session-week distributed on 4 different penile regions. The full treatment consisted of 19,200 impulses across 8 weeks. OUTCOMES: The primary clincal end point was ≥4-point difference favoring the experimental group considering the mean International Index of Erectile Function short form (IIEF-5) at last follow-up. Any statistical difference in the IIEF-5 score between the arms was stated as the primary statistical end point.
RESULTS: Between September 25, 2017, and December 3, 2018, 92 men were enrolled in the study. At last follow-up, we assessed 77 patients, 41 in the control group and 36 in the intervention group. A difference between groups was detected when accessing the final median IIEF-5 score (12.0 vs 10.0; P = .006). However, the primary clinical endpoint considering a difference ≥4-point between the arms has not been reached. When performing an exploratory analysis comparing the proportion of those individuals with an IIEF-5 score ≥17, no difference between groups was noted (17.1% vs 22.2%; P = .57). CLINICAL IMPLICATIONS: So far, the benefits arising from LiESWT for penile rehabilitation after RP have been uncertain. STRENGTHS & LIMITATIONS: This is the first trial assessing the role of LiESWT on erectile function after RP. Our study protocol included only one session per week for the experimental group, raising a query if a more intensive application could achieve better results once a statistically significant difference was found between groups. We discontinue the PDE5i use at the last session, which may have interfered in the penile vascular rehabilitation, maybe compromising the results too.
CONCLUSION: After therapy with 19,200 impulses therapy across 8 weeks, we found an improvement of the IIEF-5 score, but it was not enough to be considered clinically significant. More studies are warranted before any recommendation on this topic. Baccaglini W, Pazeto CL, Corrêa Barros EA, et al. The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial. J Sex Med 2020;17:688-694.
Copyright © 2020 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Erectile Dysfunction; Erectile Function; Penile Rehabilitation; Prostate Cancer; Shockwave

Mesh:

Substances:

Year:  2020        PMID: 32007430     DOI: 10.1016/j.jsxm.2019.12.024

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  14 in total

1.  Latest addition to a long LIST of negative penile rehabilitation trials does not come as a shock.

Authors:  Maarten Albersen
Journal:  Nat Rev Urol       Date:  2020-04       Impact factor: 14.432

Review 2.  Current management strategy of treating patients with erectile dysfunction after radical prostatectomy: a systematic review and meta-analysis.

Authors:  Dechao Feng; Cai Tang; Shengzhuo Liu; Yubo Yang; Ping Han; Wuran Wei
Journal:  Int J Impot Res       Date:  2020-10-24       Impact factor: 2.896

3.  Retrospective comparison of focused shockwave therapy and radial wave therapy for men with erectile dysfunction.

Authors:  Shannon S Wu; Kyle J Ericson; Daniel A Shoskes
Journal:  Transl Androl Urol       Date:  2020-10

4.  Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: a randomized double-blind sham-controlled clinical trial.

Authors:  Jose Vinay; Daniel Moreno; Osvaldo Rajmil; Eduard Ruiz-Castañe; Josvany Sanchez-Curbelo
Journal:  World J Urol       Date:  2020-07-21       Impact factor: 4.226

Review 5.  Male sexual dysfunction and rehabilitation strategies in the settings of salvage prostate cancer treatment.

Authors:  Eric Chung
Journal:  Int J Impot Res       Date:  2021-04-14       Impact factor: 2.896

6.  Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis.

Authors:  Ioannis Mykoniatis; Nikolaos Pyrgidis; Ioannis Sokolakis; Andreas Ouranidis; Petros Sountoulides; Anna-Bettina Haidich; Koenraad van Renterghem; Georgios Hatzichristodoulou; Dimitrios Hatzichristou
Journal:  JAMA Netw Open       Date:  2021-02-01

Review 7.  Regenerative technology to restore and preserve erectile function in men following prostate cancer treatment: evidence for penile rehabilitation in the context of prostate cancer survivorship.

Authors:  Eric Chung
Journal:  Ther Adv Urol       Date:  2021-08-21

Review 8.  Low-intensity extracorporeal shockwave therapy for erectile dysfunction.

Authors:  Onder Canguven; Kareim Khalafalla; Abdulla Al Ansari
Journal:  Arab J Urol       Date:  2021-07-05

Review 9.  Low-intensity shock wave therapy for the treatment of vasculogenic erectile dysfunction: a narrative review of technical considerations and treatment outcomes.

Authors:  Pedro Simoes de Oliveira; Matthew J Ziegelmann
Journal:  Transl Androl Urol       Date:  2021-06

10.  Low-intensity extracorporeal shock wave therapy for Peyronie's disease: a single-center experience.

Authors:  Maher Abdessater; William Akakpo; Anthony Kanbar; Jérome Parra; Thomas Seisen; Emmanuel Chartier-Kastler; Sarah J Drouin; Morgan Roupret
Journal:  Asian J Androl       Date:  2022 Jan-Feb       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.